MC10
950 Winter Street
Suite 4600
Waltham
Massachusetts
02451
United States
Tel: 781-290-0004
Fax: 781-290-0999
25 articles about MC10
-
MC10 Announces the Use of BioStamp nPoint® in Phase III Study of Huntington Disease
11/13/2019
The study is sponsored by Neurocrine Biosciences and conducted in collaboration with the Huntington Study Group.
-
MC10 and University of Vermont Announce Partnership to Advance Understanding of Gait Abnormalities in Movement Disorders
10/24/2019
MC10, Inc., the developer of BioStamp nPoint, an end-to-end system for physiological data collection and analytics, announced today a collaboration with the University of Vermont, a leading academic research institution.
-
MC10, Inc. Announces Collaboration with Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago: Innovating Precision Medicine Approaches to Improve Maternal-Infant Outcomes
10/16/2019
This collaboration bridges MC10’s expertise in wearable health solutions, DevSci’s leading-edge research on how the prenatal environment shapes early brain and behavioral development, and Lurie Children’s expertise in research at the maternal-fetal interface.
-
MC10, Inc. Announces Collaboration with University of Rochester: Development Novel Digital Biomarkers for Central Nervous System Diseases
10/2/2019
MC10, Inc., creators of the innovative wearable device BioStamp nPoint, and the University of Rochester announced today a collaboration on advancing methods of assessing Central Nervous System (CNS) diseases
-
MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System
5/14/2019
This innovative, patient-focused endeavor aims to explore the use of data from the nPoint® System in order to provide unique insights into MS clinical studies.
-
MC10 Receives FDA 510(k) Clearance for the BioStamp nPoint™ System
5/16/2018
System is designed for use in clinical trials and research studies where collection of relevant data is needed.
-
MC10 Enters Strategic Collaboration With LabCorp, Including Equity Investment, to Advance Clinical Trial Innovation and Healthcare Diagnostics
11/2/2017
As part of the collaboration, LabCorp has also made an equity investment into MC10.
-
MC10 And The Shirley Ryan AbilityLab Initiate Research Collaboration To Develop Novel Solutions For Neurodegenerative Disease And Motion Disability Rehabilitation
8/10/2017
-
MC10 And UCB Group Complete Landmark Pharmaceutical / Technology Collaboration Evaluating Patient Monitoring In Parkinson’s
1/5/2017
-
MC10 Release: Ultra-thin, Tattoo-like Wearables Enabled By New Technology Partnership
4/12/2016
-
MC10 Partners With Marubun Corporation To Add Japanese Distribution Network
4/6/2016
-
MC10 Appoints Eric K. Brandt To Its Board Of Directors
3/30/2016
-
MC10 Reshapes Research With The Introduction Of The Biostamp Research Connect System
1/6/2016
-
MC10 Joins Forces With University of Rochester To Advance Patient-Centered Research
5/28/2015
-
Former Broadcom Executive Scott Pomerantz Joins MC10 As CEO & President
9/16/2014
-
MC10 & UCB, Inc. Partner For Innovative Solutions For Patients With Neurological Disorders
7/28/2014
-
Stretchable Electronics Maker MC10 Lands $19.8 Million
12/30/2013
-
MC10 Taps Sanjay Gupta As Vice President Of Product Development
12/16/2013
-
MC10's BioStamp: The New Frontier of Medical Diagnostics With Medtronic, Inc.
6/14/2013
-
MC10 CEO, David Icke, Invited to Speak at World Economic Forum Annual Meeting in Davos
1/22/2013